Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-08-07
2007-08-07
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S011400, C514S012200, C514S013800, C530S300000, C530S317000, C530S324000, C530S326000, C530S327000, C424S009100
Reexamination Certificate
active
09743107
ABSTRACT:
The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides.
REFERENCES:
patent: 5304633 (1994-04-01), Tomita et al.
patent: 5565425 (1996-10-01), Yamamoto et al.
patent: 0629347 (1994-12-01), None
patent: 07-145196 (1995-06-01), None
patent: 07-274970 (1995-10-01), None
patent: 07-309771 (1995-11-01), None
patent: 08-040925 (1996-02-01), None
patent: 08-073499 (1996-03-01), None
patent: 08-143468 (1996-06-01), None
patent: 09040578 (1997-02-01), None
patent: 09-165342 (1997-06-01), None
patent: 98/06424 (1998-02-01), None
patent: 98/06425 (1998-02-01), None
Greene, T. and Wuts, P. , Protective Groups in Organic Synthesis, second ed., 1991, p. 293, published by John Wiley & Sons.
Daniel S. Chappel et al., “Structure-Function Relationship of Antibacterial Synthetic Peptides Homologous to a Helical Surface Region on Human Lactoferrin Against Escherichia coli Serotype 0111”, 1998, pp. 2434-2440.
Edward W. Odell et al., “Antibacterial Activity of Peptides Homologous to a Loop Region in Human Lactoferrin”, 1996, pp. 175-178.
International Search Report, Nov. 1999, 6 pp.
International Preliminary Examination Report, Nov. 2000, 11 pp., with copy of claims 1-52.
D.S. Chapple et al., “A Helical Region on Human Lactoferrin, Its Role in Antibacterial Pathogenesis”, Advances in Lactoferrin Research, 1998, vol. 443, p. 215-220.
W. Bellamy et al., “Identification of the Bactericidal Doman of Lactoferrin”, Biochimica et Biophysica Acta, 1121 (1992) 130-136.
Baltzer Lars
Dolphin Gunnar T.
Hanson Lars {dot over (A)}.
Mattsby-Baltzer Inger
Buchanan Ingersoll & Rooney P.C.
Kam Chih-Min
Pharmasurgics in Sweden AB
LandOfFree
Peptides based on the sequence of human lactoferrin and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides based on the sequence of human lactoferrin and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides based on the sequence of human lactoferrin and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3898836